Thrixen
Signal active
Organization
Contact Information
Overview
Thrixen is a biotech/Medtech company that aims to revolutionise the diagnostic technology for the detection of biomarkers at the chemistry level to unlock the next generation of diagnostic and health care monitoring tools that are simple and accessible at the point of care/need.
About
Industries
Biotechnology, Health Diagnostics
Founded
2021
Employees
1-10
Headquarters locations
Asia
Social
N/A
Profile Resume
Thrixen headquartered in Asia, operates in the Biotechnology, Health Diagnostics sector. The company focuses on Biotechnology and has secured $56.0M in funding across 8 round(s). With a team of 1-10 employees, Thrixen is actively contributing to advancements in Biotechnology. Their latest funding round, Venture Round - Thrixen, raised $7.0M. Discover more about their projects, partnerships, and impact on our platform.
Employees
N/A
Funding Rounds
Funding rounds
1
Investors
2
Lead Investors
0
Total Funding Amount
$7.0M
Details
0
Thrixen has raised a total of $7.0M in funding over 0 rounds.
| Announcement date | Transaction name | Number of Investors | Money raised | Lead Investor |
|---|
Investors
Thrixen is funded by 4 investors.
| Investor Name | Lead Investor | Funding Round | Partners |
|---|---|---|---|
| John Ballantyne | - | FUNDING ROUND - John Ballantyne | 7.0M |
| Ara Tavitian | - | FUNDING ROUND - Ara Tavitian | 7.0M |
| Thrixen | - | FUNDING ROUND - Thrixen | 7.0M |
| 22Health Ventures | - | FUNDING ROUND - 22Health Ventures | 7.0M |
Recent Activity
There is no recent news or activity for this profile.